In mid-November, the question of whether hospitals without on-site cardiac surgery should offer elective angioplasties rose to the surface as the American College of Cardiology issued revised guidelines for percutaneous coronary intervention and the American Hospital Association released a new…
The Latest
Action Products, a Hagerstown, Md.-based medical supplies company, recently ranked in the top 10 percent nationwide for GTIN Readiness, according to a company news release.
Hospital employee satisfaction is coming under the spotlight, as healthcare leaders start to realize that organizational culture is directly tied to patient satisfaction, financial results and clinical quality. Here three hospital CEOs discuss the issues that hurt employee satisfaction in…
With eight hospitals, a medical group of more than 500 employed physicians with 36 clinics and New Mexico's largest health plan, it's no surprise that Albuquerque, N.M.-based Presbyterian Healthcare Services has a big impact on its surrounding community. That's why…
Stryker Biotech reached a settlement with the US Attorney's Office for the District of Massachusetts to resolve a 2009 federal grand jury indictment, according to a Stryker news release.
Kaiser Permanente, based in Oakland, Calif., is continuing its efforts to go green with new IV equipment that are free of PVC and DEHP, two industrial chemicals used in plastics that have been shown to harm human and environmental health.
A recent poll showed 93 percent of Florida physicians support legislation designed to reform the state's current medical malpractice system, according to a Patients for Fair Compensation release.
Antimicrobial scrubs worn by healthcare personnel may decrease the risk of MRSA transmission to patients, according to research published in Infection Control and Hospital Epidemiology.
The American Association of Critical-Care Nurses has released a practice alert that updates clinical guidelines for the prevention of catheter-associated urinary tract infections.
Public reporting on risk-adjusted mortality after percutaneous coronary interventions in New York did not affect market share or physicians' decisions to leave practice from 1998-2007, according to research published in Circulation: Cardiovascular Quality and Outcomes.